14-105051155-C-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_013345.4(GPR132):āc.982G>Cā(p.Glu328Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000108 in 1,614,214 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_013345.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GPR132 | NM_013345.4 | c.982G>C | p.Glu328Gln | missense_variant | 4/4 | ENST00000329797.8 | |
LOC124903398 | XR_007064368.1 | n.335-4254C>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GPR132 | ENST00000329797.8 | c.982G>C | p.Glu328Gln | missense_variant | 4/4 | 1 | NM_013345.4 | A2 | |
GPR132 | ENST00000392585.2 | c.955G>C | p.Glu319Gln | missense_variant | 3/3 | 1 | P2 | ||
GPR132 | ENST00000551869.1 | c.*1008G>C | 3_prime_UTR_variant, NMD_transcript_variant | 3/3 | 1 | ||||
GPR132 | ENST00000539291.6 | c.982G>C | p.Glu328Gln | missense_variant | 5/5 | 2 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000103 AC: 26AN: 251356Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135888
GnomAD4 exome AF: 0.0000944 AC: 138AN: 1461890Hom.: 1 Cov.: 32 AF XY: 0.0000976 AC XY: 71AN XY: 727244
GnomAD4 genome AF: 0.000243 AC: 37AN: 152324Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74492
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at